Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
about
The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinomaLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaPoly(malic acid) bearing Doxorubicin and N-Acetyl Galactosamine as a site-specific prodrug for targeting hepatocellular carcinoma.Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.Atmospheric particulate matter2.5 promotes the migration and invasion of hepatocellular carcinoma cells.Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.Targeting PEPT1: a novel strategy to improve the antitumor efficacy of doxorubicin in human hepatocellular carcinoma therapyAntitumor activities of Liver-targeting peptide modified Recombinant human Endostatin in BALB/c-nu mice with Hepatocellular carcinoma.Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF-κB inhibition and mitochondrial dysfunction.Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma.Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.Orthotopic hepatic cancer: radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy.Augmented Anticancer Effects of Cantharidin with Liposomal Encapsulation: In Vitro and In Vivo Evaluation.Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate.Strategies on Nanodiagnostics and Nanotherapies of the Three Common Cancers.Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells.
P2860
Q28066407-19EF76DB-C8B1-4AC2-9FC7-71D65CFD3E3EQ28068437-A42F381E-9D7C-4C91-AC0C-8770E71E3624Q38709628-F5C0586E-A3D0-4603-9943-8C95D19817DDQ38727481-B8EEFCC5-3508-4A49-ACC7-C94E191A1492Q38776703-26553BED-FAB3-4947-BEFB-7523F8A744BBQ39378285-18955179-65D7-451C-A2B2-F88E162559EFQ41093055-BF397495-CF19-44EB-8757-AFBA72E214CCQ42620896-989F5AB7-B5C2-4B74-A445-A6082B58E18DQ46489500-7B530CA3-E18C-44F6-BFC9-B0A8D06D5EBCQ47097723-89DA6C18-7CDB-42A0-9609-7B7684615BB9Q47240392-09076FD1-B999-4A2E-8A3C-10A967AB34C5Q50914838-4597412E-348C-468D-B19C-709FBDFA9C9DQ52723935-919B1BFD-7B35-41F8-BE85-FD4DBF2BEBADQ52763843-FCC02FAE-59DA-478B-AB43-7A6AB7204430Q52812169-763B6F36-9144-4A76-B557-916C5FC3C00BQ54988869-60FB7C44-6ABA-4014-AB0D-8F600409643BQ55447240-B1C08F54-1C78-4859-B86F-B26C7353B75F
P2860
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
@en
type
label
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
@en
prefLabel
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
@en
P2093
P1476
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
@en
P2093
Congcong Lin
Hongqi Zhang
Huei Leng Helena Ng
Limin Zhou
Yanbo Zhang
Zhijun Yang
P304
P356
10.1016/J.NANO.2015.12.381
P577
2016-01-06T00:00:00Z